Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info
Collaborator of
J Cardiovasc Thorac Res
. 2022;14(4): 253-257. doi:
10.34172/jcvtr.2022.30559
PMID:
36699557
PMCID:
PMC9871165
Short Communication
Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study
Azar Hadadi
1
, Sina Kazemian
2
, Mahan Shafie
3
,
4
, Arezoo Ahmadi
5
, Abbas Soleimani
6
, Haleh Ashraf
2
,
7
*
Cited by CrossRef: 0
1- Kelleni M. Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin.
Ir J Med Sci
. 2024;193(4):2077
[Crossref]